Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call Transcript

Mirum Pharmaceut…

X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

X4 Pharmaceutica…

Maintenance Tips for Industrial Cold Storage in Pharmaceuticals – Daily Business

Temperature excu…

Ligand Pharmaceuticals: 2026 Guidance May Already Be Included In Current Valuation

Ligand Pharmaceu…

ORIC Pharmaceuticals, Inc. (ORIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ORIC Pharmaceuti…

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference – Slideshow

Xenon Pharmaceut…

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Interim Results From Obesity Candidates and Advances in Treatment Approaches – Slideshow

Arrowhead Pharma…

Madrigal Pharmaceuticals: My Take On Prospects For 2026 Leads To Rating Downgrade

Madrigal Pharmac…

Agios Pharmaceuticals, Inc. (AGIO) Discusses FDA Approval of AQVESME for Anemia in Alpha and Beta Thalassemia Transcript

Agios Pharmaceut…

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

Oramed Pharmaceu…

Reviva Pharmaceuticals: Brilaroxazine Seems Efficacious, But Progress Is Slow And Dilution Is High

Reviva Pharmaceu…

Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day – Slideshow

Ligand Pharmaceu…